Login / Signup

Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects.

Amedeo Ferdinando CapettiGiuseppe Vittorio De SocioMaria V CossuGaetana SterrantinoGiovanni CenderelloAnnamaria CattelanGianmaria BaldinAlessandro SoriaNiccolò RiccardiFosca P NieroBenedetto M CelesiaGiorgio BarbariniStefano RusconiGiuliano Rizzardini
Published in: HIV clinical trials (2019)
These long-term data confirm the reliability of the two-drug regimen consisting of bDRV plus DTG in salvage settings in HIV-1 infection.
Keyphrases
  • antiretroviral therapy
  • hiv infected
  • hiv infected patients
  • human immunodeficiency virus
  • electronic health record
  • emergency department
  • machine learning
  • adverse drug
  • replacement therapy